Thank you for watching the recent activity 'Aldosterone Dysregulation in Hypertension: Insights from Emerging Data at the ESC'. To assess the success of this activity, we would be grateful if you could answer the following short survey.

If you wish to watch again or share with colleagues, you can watch, here.

This Independent Medical Education programme is supported by an unrestricted educational grant from AstraZeneca.

Question Title

1. Having taken part in this activity, which of the following reflects your current understanding of aldosterone dysregulation in uncontrolled hypertension?

Question Title

2. Having taken part in this activity how familiar are you now with clinical trials for emerging aldosterone blockade medications such as aldosterone synthase inhibitors (ASIs)?

Question Title

3. Has this activity improved your confidence explaining how emerging aldosterone blockade therapies may impact existing clinical guidelines?

T